ENGINEERING A HIGHLY POTENT AND SELECTIVE HNTX-III MUTANT AGAINST THE NAV1.7 SODIUM CHANNEL FOR TREATMENT OF PAIN

被引：0
|
作者：
Zhang, Yunxiao [1 ]
Peng, Dezheng [1 ]
Chen, Minzhi [1 ]
Li, Jiayan [1 ]
Li, Dan [1 ]
Liu, Zhonghua [1 ]
Liang, Songping [1 ]
机构：
[1] Hunan Normal Univ, Natl &Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China
来源：
TOXICON | 2019年 / 158卷
关键词：
Nav1.7; HNTX-III; Analgesia; Structure activity relationship;
D O I：
10.1016/j.toxicon.2018.10.195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
186
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [1] Engineering of highly potent and selective HNTX-III mutant against hNav1.7 sodium channel for treatment of pain
    Zhang, Yunxiao
    Wang, Li
    Peng, Dezheng
    Zhang, Qingfeng
    Yang, Qiuchu
    Li, Jiayan
    Li, Dan
    Tang, Dongfang
    Chen, Minzhi
    Liang, Songping
    Liu, Yu
    Wang, Sheng
    Liu, Zhonghua
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [2] Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain
    Shcherbatko, Anatoly
    Rossi, Andrea
    Foletti, Davide
    Zhu, Guoyun
    Bogin, Oren
    Casas, Meritxell Galindo
    Rickert, Mathias
    Hasa-Moreno, Adela
    Bartsevich, Victor
    Crameri, Andreas
    Steiner, Alexander R.
    Henningsen, Robert
    Gill, Avinash
    Pons, Jaume
    Shelton, David L.
    Rajpal, Arvind
    Strop, Pavel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (27) : 13974 - 13986
  • [3] Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain
    Wu, Yong-Jin
    Guernon, Jason
    Shi, Jianliang
    Ditta, Jonathan
    Robbins, Kevin J.
    Rajamani, Ramkumar
    Easton, Amy
    Newton, Amy
    Bourin, Clotilde
    Mosure, Kathleen
    Soars, Matthew G.
    Knox, Ronald J.
    Matchett, Michele
    Pieschl, Rick L.
    Post-Munson, Debra J.
    Wang, Shuya
    Herrington, James
    Graef, John
    Newberry, Kimberly
    Bristow, Linda J.
    Meanwell, Nicholas A.
    Olson, Richard
    Thompson, Lorin A.
    Dzierba, Carolyn
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) : 2513 - 2525
  • [4] Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the NaV1.7 Sodium Channel
    Murray, Justin K.
    Ligutti, Joseph
    Liu, Dong
    Zou, Anruo
    Poppe, Leszek
    Li, Hongyan
    Andrews, Kristin L.
    Moyer, Bryan D.
    McDonough, Stefan I.
    Favreau, Philippe
    Stoecklin, Reto
    Miranda, Les P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (05) : 2299 - 2314
  • [5] Evaluation of Selective NaV1.7 Inhibitors for the Treatment of Ocular Pain
    Delwig, Anton
    Pajouhesh, Hassan
    Yeomans, David
    Du Bois, Justin
    Miljanich, George
    Mulcahy, John
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [6] Familial pain syndromes from mutations of the Nav1.7 sodium channel
    Fischer, Tanya Z.
    Waxman, Stephen G.
    YEAR IN NEUROLOGY 2, 2010, 1184 : 196 - 207
  • [7] Discovery of PF-05089771: A potent, subtype selective Nav1.7 inhibitor for the treatment of pain
    Swain, Nigel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [8] Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Nav1.7
    Lee, Su-Jin
    Kim, Dong-Hyun
    Hahn, Sang June
    Waxman, Stephen G.
    Choi, Jin-Sung
    NEUROSCIENCE LETTERS, 2017, 639 : 1 - 7
  • [9] Discovery of indole- and indazole-acylsulfonamides as potent and selective Nav1.7 inhibitors for the treatment of pain
    Luo, Guanglin
    Chen, Ling
    Easton, Amy
    Newton, Amy
    Bourin, Clotilde
    Shields, Eric
    Mosure, Kathleen
    Soar, Mattew
    Knox, Ronald
    Matchett, Michele
    Pieschl, Rick
    Post-Munson, Debra
    Wang, Shuya
    Herrington, James
    Graef, John
    Newberry, Kimberly
    Bristow, Linda
    Meanwell, Nicholas
    Thompson, Lorin
    Dzierba, Carolyn
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [10] Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain
    Luo, Guanglin
    Chen, Ling
    Easton, Amy
    Newton, Amy
    Bourin, Clotilde
    Shields, Eric
    Mosure, Kathy
    Soars, Matthew G.
    Knox, Ronald J.
    Matchett, Michele
    Pieschl, Rick L.
    Post-Munson, Debra J.
    Wang, Shuya
    Herrington, James
    Graef, John
    Newberry, Kimberly
    Sivarao, Digavalli V.
    Senapati, Arun
    Bristow, Linda J.
    Meanwell, Nicholas A.
    Thompson, Lorin A.
    Dzierba, Carolyn
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (02) : 831 - 856
12345